New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 13, 2014
07:59 EDTPRTAProthena data somewhat misunderstood by investors, says RBC Capital
RBC Capital believes the pullback in Prothena's stock reflected some misunderstanding of data on the company's NEOD001, a monoclonal antibody in clinical development for the treatment of patients with AL amyloidosis and persistent organ dysfunction. The firm believes that the data indicates that the drug is having a real impact. It keeps a $52 price target and Outperform rating on the stock.
News For PRTA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 10, 2014
15:53 EDTPRTACredit Suisse to hold a conference
Healthcare Conference is being held in Scottsdale, Arizona on November 10-13 with webcasted company presentations to begin on November 11 at 10:30 am; not all company presentations may be webcasted. Webcast Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use